Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

BASF reports on novel thrombin inhibitors

Oct. 18, 1996

Benzimidazole derivatives for use in heart failure

Oct. 18, 1996

Tsumura discloses agents for atherosclerosis

Oct. 18, 1996

PAF synthesis modulators described for inflammation

Oct. 18, 1996

Leukotriene antagonists from Sankyo

Oct. 18, 1996

Neuroprotective calpain inhibitors from Warner-Lambert

Oct. 18, 1996

Huperzine A analogues claimed for treatment of AD

Oct. 18, 1996

Lilly's benzimidazole compounds for beta-amyloid peptide-associated disorders

Oct. 18, 1996

Peptidomimetic compounds disclosed by University of Pennsylvania

Oct. 18, 1996

Antipsychotic agents from Asahi Chem.

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...